Search
Roddenberry Foundation Gives $5 Million to J. Craig Venter Institute for Sustainable Wastewater Treatment Technology Development
LA JOLLA, CA—July 10, 2013—The J. Craig Venter Institute (JCVI), a not-for-profit genomic research organization, today announced that the Roddenberry Foundation has awarded JCVI scientist Orianna Bretschger, Ph.D., a $5 million dollar grant to continue her research into new wastewater treatment technologies. The five year grant will support the development of Bretschger’s BioElectrochemical Sanitation Technology (BEST), which uses microbial fuel cells (MFCs) to clean wastewater and...
J. Craig Venter Institute Announces November 9, 2013 Black Tie Event to Celebrate Opening of New California Sustainable Laboratory
ROCKVILLE, MD and SAN DIEGO, CA—July 2, 2013—The J. Craig Venter Institute (JCVI) today announced November 9, 2013 as the date for a black tie fund raising event to celebrate the opening of their new sustainable laboratory in La Jolla, CA. Capital One Bank has generously signed on as the highest level, “Visionary Sponsor” for the event. Other sponsors to date include: ZGF Architects and McCarthy Building Companies, who have been named as “Explorer Sponsors”. The beautiful...
Prepared Statement on the Supreme Court Human Gene Patent Ruling
FOR IMMEDIATE RELEASE—La Jolla, CA June 13, 2013 J. Craig Venter, Ph.D., Founder and CEO, Synthetic Genomics Inc. and Founder and CEO, the J. Craig Venter Institute “Today the United States Supreme Court ruled on the validity of BRAC1 and BRAC2 human gene patents stating that, ‘A naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated, but cDNA is patent eligible because it is not naturally occurring,’ is consistent with...
Research Team Publishes New Methods for Synthetic Generation of Influenza Vaccines
LA JOLLA, CA and ROCKVILLE, MD — May 15, 2013 — A team of international researchers from the J. Craig Venter Institute (JCVI), Synthetic Genomics Inc. (SGI), Novartis Vaccines and Diagnostics, the Biomedical Advanced Research and Development Authority (BARDA, US Department of Health and Human Services), and Institut fur Virologie, Universitat, has published a study detailing new methods to rapidly generate influenza vaccine seeds by using synthetic genomics tools and...
J. Craig Venter Institute’s Mobile Genomics Lab Launches First School Visits in San Diego County
LA JOLLA, CA — May 14, 2013 — The J. Craig Venter Institute (JCVI) announced today the launch of their mobile genomics laboratory program in the San Diego, California area. The DiscoverGenomics! Mobile Laboratory is a self-sufficient laboratory on wheels providing middle school students and teachers an opportunity to learn current bioscience concepts and to master the use of the cutting-edge laboratory equipment found in life science research facilities. Beginning...
Real Time Genomics and J. Craig Venter Institute Embark on Strategic Research Initiative
SAN FRANCISCO BAY AREA, California, May 1, 2013 -- Real Time Genomics, Inc. (RTG), the genome analytics company, today announced a long-term strategic collaboration with the J. Craig Venter Institute (JCVI), a not-for-profit genomic research institute, aimed at understanding and analyzing the genetic changes that induced pluripotent stem cells may acquire during the process of differentiation. RTG and JCVI also announced today a collaboration to discover and validate highly accurate human...
Dr. J. Robert Beyster and Betty J. Beyster Make $2.5 Million Pledge to the J. Craig Venter Institute
LA JOLLA, CA — April 17, 2013 — The J. Craig Venter Institute (JCVI) today announced that J. Robert Beyster and Betty J. Beyster will donate approximately $2.5 million to the Institute. The money will be used to support the completion of the new J. Craig Venter Institute sustainable laboratory currently under construction on the University of California, San Diego campus in La Jolla, CA. In recognition of this generous gift, the third floor ocean view conference room and terrace will...
Prepared Statement from J. Craig Venter, Ph.D., and the J. Craig Venter Institute and Synthetic Genomics Vaccines, Inc. on the H7N9 avian flu strain in China
April 9, 2013 "In response to a request from the United States Centers for Disease Control (CDC) and Biomedical Advanced Research and Development Authority (BARDA), and after the H7N9 flu virus gene sequences were made publicly available through the Global Initiative on Sharing All Influenza Data (GISAID), the J. Craig Venter Institute (JCVI) and Synthetic Genomics Vaccines, Inc (SGVI) began working with Novartis to synthesize the genes of the new viral strain and supplied these...
Venter Institute-Led Team Recovers and Sequences Genome of Periodontal Pathogen from Biofilm in Hospital Sink using Single-Cell Genomics
LA JOLLA, CA — April 5, 2013 — A team of researchers led by scientists from the J. Craig Venter Institute (JCVI) has published a study outlining the recovery and genomic analysis, using single-cell genomic techniques, of a periodontal pathogen, Porphyromonas gingivalis, from a hospital sink. This is the first time that a single-cell genome sequencing approach was used to isolate and analyze a single microbe from a biofilm in a healthcare setting. The team, led by JCVI's Jeffrey McLean...
J. Craig Venter Named MRIGlobal 2013 Citation Award Winner
Kansas City, Mo. — The MRIGlobal Board of Directors and Trustees today announced that it will present its annual Citation Award this year to J. Craig Venter, Ph.D., one of the leading scientists of the 21st century. Dr. Venter is the Founder, Chairman, and Chief Executive Officer of the J. Craig Venter Institute, a not-for-profit research organization dedicated to human, microbial, plant, synthetic, and environmental research. He also is Founder and Chief Executive Officer of...